Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 93-97

  Shrivastav, Anuraag ^a,c   Sharma, Anil R ^a,c   Bajaj, Gagan ^a,c   Charavaryamath, Chandrashekhar ^b   Ezzat, Wendelin ^a,d   Spafford, Peter ^d   Gore Hickman, Rick ^d   Singh, Baljit ^b   Copete, Maria A ^b   Sharma, Rajendra K ^a,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c SASKATCHEWAN CANCER AGENCY   (Canada)

^d Saskatoon Health Region St Pauls Hospital   (Canada)

Author keywords

N myristoyltransferase; N myristoyltransferase inhibitor protein hsc70; Oral squamous cell carcinoma

Indexed keywords

ACYLTRANSFERASE; GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; MYRISTIC ACID; N MYRISTOYLTRANSFERASE INHIBITOR PROTEIN 71, HUMAN; N-MYRISTOYLTRANSFERASE INHIBITOR PROTEIN 71, HUMAN; PROTEIN N MYRISTOYLTRANSFERASE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PROTEIN PROCESSING; SQUAMOUS CELL CARCINOMA;

ACYLTRANSFERASES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; MYRISTIC ACID; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 34548029184     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.93     Document Type: Article

References (32)

1. Boutin JA: Myristoylation. Cell Signal 9: 15-35, 1997.
2. Farazi TA, Waksman G and Gordon JI: The biology and enzymology of protein N-myristoylation. J Biol Chem 276: 39501-39504, 2001.
3. Stehelin D, Varmus HE, Bishop JM and Vogt PK: DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170-173, 1976.
4. Krueger JG, Garber EA, Goldberg AR and Hanafusa H: Changes in amino-terminal sequences of pp60src lead to decreased membrane association and decreased in vivo tumorigenicity. Cell 28: 889-896, 1982.
5. Yeatman TJ: A renaissance for SRC. Nat Rev Cancer 4: 470-480, 2004.
6. Dehm SM and Bonham K: SRC gene expression in human cancer: the role of transcriptional activation. Biochem Cell Biol 82: 263-274, 2004. (Pubitemid 38680178)
7. Rajala RV, Datla RS, Moyana TN, Kakkar R, Carlsen SA and Sharma RK: N-myristoyltransferase. Mol Cell Biochem 204: 135-155, 2000. (Pubitemid 30111767)
8. Ebiike H, Masubuchi M, Liu P, et al: Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2. Bioorg Med Chem Lett 12: 607-610, 2002. (Pubitemid 34158904)
9. Felsted RL, Glover CJ and Hartman K: Protein N-myristoylation as a chemotherapeutic target for cancer. J Natl Cancer Inst 87: 1571-1573, 1995.
10. Shrivastav A, Selvakumar P, Bajaj G, Lu Y, Dimmock JR and Sharma RK: Regulation of N-Myristoyltransferase by novel inhibitor proteins. Cell Biochem Biophys 43: 189-202, 2005. (Pubitemid 41095283)
11. Magnuson BA, Raju RV, Moyana TN and Sharma RK: Increased N-myristoyltransferase activity observed in rat and human colonic tumors. J Natl Cancer Inst 87: 1630-1635, 1995.
12. Raju RV, Moyana TN and Sharma RK: N-Myristoyltransferase overexpression in human colorectal adenocarcinomas. Exp Cell Res 235: 145-154, 1997. (Pubitemid 27381692)
13. Parang K, Wiebe LI, Knaus EE, Huang JS, Tyrrell DL and Csizmadia F: In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses. Antiviral Res 34: 75-90, 1997. (Pubitemid 27220184)
14. Rajala RV, Radhi JM, Kakkar R, Datla RS and Sharma RK: Increased expression of N-myristoyltransferase in gallbladder carcinomas. Cancer 88: 1992-1999, 2000. (Pubitemid 30233199)
15. Selvakumar P, Lakshmikuttyamma A, Shrivastav A, Das S, Dimmock JR and Sharma RK: Potential role of N-myristoyltransferase in cancer. Prog Lipid Res 46: 1-36, 2007. (Pubitemid 44794417)
16. Schliephake H: Prognostic relevance of molecular markers of oral cancer (Review). Int J Oral Maxillofac Surg 32: 233-245, 2003.
17. Raju RV, Datla RS and Sharma RK: Overexpression of human N-myristoyltransferase utilizing a T7 polymerase gene expression system. Protein Expr Purif 7: 431-437, 1996. (Pubitemid 26263250)
18. King MJ and Sharma RK: N-myristoyl transferase assay using phosphocellulose paper binding. Anal Biochem 199: 149-153, 1991.
19. Shrivastav A, Pasha MK, Selvakumar P, Singh B and Sharma RK: Expression, localization, and correlation of N-myristoyltransferase and its inhibitor in bovine eye. Invest Ophthalmol Vis Sci 45: 1674-1679, 2004. (Pubitemid 38868957)
20. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
21. Biscardi JS, Tice DA and Parsons SJ: c-Src, receptor tyrosine kinases, and human cancer. Adv Cancer Res 76: 61-119, 1999. (Pubitemid 29190881)
22. Bolen JB, Veillette A, Schwartz AM, DeSeau V and Rosen N: Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 84: 2251-2255, 1987. (Pubitemid 17075849)
23. Buss JE, Solski PA, Schaeffer JP, MacDonald MJ and Der CJ: Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal. Science 243: 1600-1603, 1989. (Pubitemid 19090510)
24. Cadwallader KA, Paterson H, Macdonald SG and Hancock JF: N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Mol Cell Biol 14: 4722-4730, 1994. (Pubitemid 24196822)
25. Rajala RV, Kakkar R, Kanthan R, et al: Altered expression and localization of N-myristoyltransferase in experimentally induced rat model of ischemia-reperfusion. J Cell Biochem 86: 509-519, 2002. (Pubitemid 36076168)
26. King MJ and Sharma RK: Identification, purification and characterization of a membrane-associated N-myristoyltransferase inhibitor protein from bovine brain. Biochem J 291: 635-639, 1993. (Pubitemid 23127052)
27. Selvakumar P, Lakshmikuttyamma A, Pasha MK, et al: N-myristoyltransferase inhibitor protein is homologous to heat shock cognate protein 70. J Cell Biochem 92: 573-578, 2004.
28. Azuma K, Shichijo S, Takedatsu H, Komatsu N, Sawamizu H and Itoh K: Heat shock cognate protein 70 encodes antigenic epitopes recognised by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients. Br J Cancer 89: 1079-1085, 2003. (Pubitemid 37239215)
29. Maehara Y, Oki E, Abe T, Tokunaga E, Shibahara K, Kakeji Y and Sugimachi K: Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer. Oncology 58: 144-151, 2000. (Pubitemid 30113865)
30. Kaur J, Srivastava A and Ralhan R: Expression of 70-kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity. Oral Oncol 34: 496-501, 1998. (Pubitemid 28546864)
31. Shrivastav A, Singh NK, Tripathi P, George T, Dimmock JR and Sharma RK: Copper(II) and manganese(III) complexes of N′-[(2-hydroxy phenyl) carbonothioyl] pyridine-2-carbohydrazide: novel therapeutic agents for cancer. Biochimie 88: 1209-1216, 2006.
32. Ducker CE, Upson JJ, French KJ and Smith CD: Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis. Mol Cancer Res 3: 463-476, 2005. (Pubitemid 41232608)